# Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine

> **NCT02514018** · PHASE4 · UNKNOWN · sponsor: **University of Toronto** · enrollment: 45 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Live-attenuated varicella-zoster virus vaccine

## Key facts

- **NCT ID:** NCT02514018
- **Lead sponsor:** University of Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2017-01
- **Final completion:** 2017-07
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-10-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02514018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02514018, "Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02514018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*